Stem cells in musculoskeletal system for clinical application.
10.5124/jkma.2011.54.5.491
- Author:
Byoung Hyun MIN
1
;
Tian Zhu LI
Author Information
1. Department of Orthopedic Surgery, Ajou University School of Medicine, Ajou University Medical Center, Suwon, Korea. bhmin@ajou.ac.kr
- Publication Type:Original Article
- Keywords:
Stem cells;
Musculoskeletal system;
Tissue engineering
- MeSH:
Biocompatible Materials;
Cartilage;
Fibroblasts;
Humans;
Mesenchymal Stromal Cells;
Muscles;
Musculoskeletal Diseases;
Musculoskeletal System;
Stem Cells;
Tissue Engineering
- From:Journal of the Korean Medical Association
2011;54(5):491-501
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Mesenchymal stem cells (MSCs) play a crucial role in the proliferation and differentiation of human tissue such as bone, cartilage, muscle, fat, and fibroblasts. Various surgical techniques have been developed for the repair of the musculoskeletal system, but they can be often limited. Thus, the efforts that can be employed in treatment for MSCs population of degenerative musculoskeletal diseases are underway. Patients who have a musculoskeletal disease with low numbers of functional MSCs will be treated using a focus on cell-based therapy. The ideal clinical application is to engineer material/scaffolds that are capable of delivering therapeutic cells that can regenerate and repair damaged tissue. The ability related to MSCs differentiation using biomaterial systems offers a minimally invasive therapeutic option for diseases of the musculoskelecal system and tissue repair. Understanding the natural mechanisms for this delivery is essential to the success of tissue engineering biomaterials that deliver therapeutic cells.
